Literature DB >> 15377282

Topological assignment of the N-terminal extension of plasma gelsolin to the gelsolin surface.

Ulrike Fock1, Brigitte M Jockusch, Wolf-Dieter Schubert, Horst Hinssen.   

Abstract

The actin-binding protein gelsolin is highly conserved in vertebrates and exists in two isoforms, a cytoplasmic and an extracellular variant, generated by alternative splicing. In mammals, these isoforms differ only by an N-terminal extension in plasma gelsolin, a short sequence of up to 25 amino acids. Cells and tissues may contain both variants, as plasma gelsolin is secreted by many cell types. The tertiary structure of equine plasma gelsolin has been elucidated, but without any information on the N-terminal extension. In this paper, we present topographical data on the N-terminal extension, derived using a biochemical and immunological approach. For this purpose, a monoclonal antibody was generated that exclusively recognizes cytoplasmic gelsolin but not the extracellular variant and thus allows isoform-specific immunodetection and quantification of cytoplasmic gelsolin in the presence of plasma gelsolin. Using limited proteolysis and pepscan analysis, we mapped the binding epitope and localized it within two regions in segment 1 of the cytoplasmic gelsolin sequence: Tyr34-Ile45 and Leu64-Ile78. In the tertiary structure of the cytoplasmic variant, these sequences are mutually adjacent and located in the proximity of the N-terminus. We therefore conclude that the binding site of the antibody is covered by the N-terminal extension in plasma gelsolin and thus sterically hinders antibody binding. Our results allow for a topological model of the N-terminal extension on the surface of the gelsolin molecule, which was unknown previously.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15377282      PMCID: PMC1134740          DOI: 10.1042/BJ20040875

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

Review 1.  Structure and function of gelsolin.

Authors:  L D Burtnick; R C Robinson; S Choe
Journal:  Results Probl Cell Differ       Date:  2001

Review 2.  Gelsolin, a multifunctional actin regulatory protein.

Authors:  H Q Sun; M Yamamoto; M Mejillano; H L Yin
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

3.  Ca-dependent binding of actin to gelsolin.

Authors:  Sofia Khaitlina; Horst Hinssen
Journal:  FEBS Lett       Date:  2002-06-19       Impact factor: 4.124

4.  The crystal structure of plasma gelsolin: implications for actin severing, capping, and nucleation.

Authors:  L D Burtnick; E K Koepf; J Grimes; E Y Jones; D I Stuart; P J McLaughlin; R C Robinson
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

5.  Differential colocalization of profilin with microfilaments in PtK2 cells.

Authors:  O Mayboroda; K Schlüter; B M Jockusch
Journal:  Cell Motil Cytoskeleton       Date:  1997

6.  Equus caballus gelsolin--cDNA sequence and protein structural implications.

Authors:  E K Koepf; J Hewitt; H Vo; R T Macgillivray; L D Burtnick
Journal:  Eur J Biochem       Date:  1998-02-01

7.  Functional consequences of disulfide bond formation in gelsolin.

Authors:  P G Allen
Journal:  FEBS Lett       Date:  1997-01-13       Impact factor: 4.124

Review 8.  Functions of gelsolin: motility, signaling, apoptosis, cancer.

Authors:  D J Kwiatkowski
Journal:  Curr Opin Cell Biol       Date:  1999-02       Impact factor: 8.382

9.  Ca2+ regulation of gelsolin by its C-terminal tail.

Authors:  K M Lin; M Mejillano; H L Yin
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

10.  Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody.

Authors:  S M Gonsior; S Platz; S Buchmeier; U Scheer; B M Jockusch; H Hinssen
Journal:  J Cell Sci       Date:  1999-03       Impact factor: 5.285

View more
  1 in total

Review 1.  Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target.

Authors:  Ewelina Piktel; Ilya Levental; Bonita Durnaś; Paul A Janmey; Robert Bucki
Journal:  Int J Mol Sci       Date:  2018-08-25       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.